Borow, K., Mason, R., & Vijayaraghavan, K. (2017). Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review. Cardiorenal Medicine, 8(1), 18-30. https://doi.org/10.1159/000479391